FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152555903> ?p ?o ?g. }

• W2152555903 endingPage "64" @default.
• W2152555903 startingPage "57" @default.
• W2152555903 abstract "Background. A dramatic decrease in the incidence of invasive pneumococcal disease (IPD) was observed among children and adults in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7). Little is known about the incidence of IPD after PCV7 licensure in Europe. The objective of this study was to examine changes in the prevalence of IPD among adults in the PCV7 era. Methods. We undertook a prospective study involving adults with IPD who required hospital admission in the southern area of Barcelona, Spain. Three periods were studied: the pre-PCV7 period (1997–2001), the early PCV7 period (2002–2004), and the late PCV7 period (2005–2007). Results. A total of 1007 episodes of IPD were observed. Rates of IPD among adults increased from 13.9 to 14.6 episodes per 100,000 population between the pre-PCV7 period and the early PCV7 period (P=.6) and then to 19.55 episodes per 100,000 population in the late PCV7 period (P<.001). The rates of IPD among adults due to non-PCV7 serotypes increased from 8.4 to 9.7 episodes per 100,000 population between the pre-PCV7 period and the early PCV7 period (P=.15) and then to 15.3 episodes per 100,000 population in the late PCV7 period (P<.001); IPD due to PCV7 serotypes decreased from 5.6 to 4.9 episodes per 100,000 population between the pre-PCV7 period and the early PCV7 period (P=.3), then to 4.3 episodes per 100,000 population in the late PCV7 period (P=.056). Among people aged ⩾65 years, IPD due to PCV7 serotypes decreased from 19.5 to 14.6 episodes per 100,000 population between the pre-PCV7 period and the early PCV7 period (P=.13), then to 12.3 episodes per 100,000 population in the late PCV7 period (P=.02). A decrease in the prevalence of antibiotic-resistant pneumococci in the late PCV7 period was associated with a decrease in the prevalence of multidrug-resistant PCV7 clones (Spain23F-ST81, Spain6B-ST90, and ST8819F) and an increase in the prevalence of non-PCV7 antibiotic-susceptible clones (ST3061, ST1917F, ST98912F, and ST43322F). Conclusions. Rates of IPD among adults increased in Barcelona in the late PCV7 period, coinciding with a clonal expansion of non-PCV7 serotypes. In contrast, rates of IPD caused by PCV7 serotypes decreased among people aged ⩾65 years, which suggests the development of a herd immunity." @default.
• W2152555903 created "2016-06-24" @default.
• W2152555903 creator A5001041683 @default.
• W2152555903 creator A5012842573 @default.
• W2152555903 creator A5025521012 @default.
• W2152555903 creator A5033886002 @default.
• W2152555903 creator A5050223354 @default.
• W2152555903 creator A5055456444 @default.
• W2152555903 creator A5067259476 @default.
• W2152555903 creator A5081460840 @default.
• W2152555903 creator A5082380268 @default.
• W2152555903 date "2009-01-01" @default.
• W2152555903 modified "2023-10-11" @default.
• W2152555903 title "Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007" @default.
• W2152555903 cites W1538705233 @default.
• W2152555903 cites W1849150246 @default.
• W2152555903 cites W1853177783 @default.
• W2152555903 cites W1933771256 @default.
• W2152555903 cites W1971935056 @default.
• W2152555903 cites W1984739827 @default.
• W2152555903 cites W1987330843 @default.
• W2152555903 cites W2014974296 @default.
• W2152555903 cites W2035758731 @default.
• W2152555903 cites W2055234322 @default.
• W2152555903 cites W2068052868 @default.
• W2152555903 cites W2068383131 @default.
• W2152555903 cites W2069992170 @default.
• W2152555903 cites W2083546946 @default.
• W2152555903 cites W2096757611 @default.
• W2152555903 cites W2098218091 @default.
• W2152555903 cites W2098483219 @default.
• W2152555903 cites W2101628365 @default.
• W2152555903 cites W2103261508 @default.
• W2152555903 cites W2103637444 @default.
• W2152555903 cites W2106559589 @default.
• W2152555903 cites W2111717771 @default.
• W2152555903 cites W2114808661 @default.
• W2152555903 cites W2116813766 @default.
• W2152555903 cites W2122017857 @default.
• W2152555903 cites W2134606926 @default.
• W2152555903 cites W2146277354 @default.
• W2152555903 cites W2149692108 @default.
• W2152555903 cites W2154294525 @default.
• W2152555903 cites W2156956165 @default.
• W2152555903 cites W2166642863 @default.
• W2152555903 cites W2331102377 @default.
• W2152555903 doi "https://doi.org/10.1086/594125" @default.
• W2152555903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19035779" @default.
• W2152555903 hasPublicationYear "2009" @default.
• W2152555903 type Work @default.
• W2152555903 sameAs 2152555903 @default.
• W2152555903 citedByCount "175" @default.
• W2152555903 countsByYear W21525559032012 @default.
• W2152555903 countsByYear W21525559032013 @default.
• W2152555903 countsByYear W21525559032014 @default.
• W2152555903 countsByYear W21525559032015 @default.
• W2152555903 countsByYear W21525559032016 @default.
• W2152555903 countsByYear W21525559032017 @default.
• W2152555903 countsByYear W21525559032018 @default.
• W2152555903 countsByYear W21525559032019 @default.
• W2152555903 countsByYear W21525559032020 @default.
• W2152555903 countsByYear W21525559032021 @default.
• W2152555903 countsByYear W21525559032022 @default.
• W2152555903 countsByYear W21525559032023 @default.
• W2152555903 crossrefType "journal-article" @default.
• W2152555903 hasAuthorship W2152555903A5001041683 @default.
• W2152555903 hasAuthorship W2152555903A5012842573 @default.
• W2152555903 hasAuthorship W2152555903A5025521012 @default.
• W2152555903 hasAuthorship W2152555903A5033886002 @default.
• W2152555903 hasAuthorship W2152555903A5050223354 @default.
• W2152555903 hasAuthorship W2152555903A5055456444 @default.
• W2152555903 hasAuthorship W2152555903A5067259476 @default.
• W2152555903 hasAuthorship W2152555903A5081460840 @default.
• W2152555903 hasAuthorship W2152555903A5082380268 @default.
• W2152555903 hasBestOaLocation W21525559031 @default.
• W2152555903 hasConcept C120665830 @default.
• W2152555903 hasConcept C121332964 @default.
• W2152555903 hasConcept C187212893 @default.
• W2152555903 hasConcept C2778866548 @default.
• W2152555903 hasConcept C2781253189 @default.
• W2152555903 hasConcept C2908647359 @default.
• W2152555903 hasConcept C501593827 @default.
• W2152555903 hasConcept C61511704 @default.
• W2152555903 hasConcept C71924100 @default.
• W2152555903 hasConcept C86803240 @default.
• W2152555903 hasConcept C89423630 @default.
• W2152555903 hasConcept C99454951 @default.
• W2152555903 hasConceptScore W2152555903C120665830 @default.
• W2152555903 hasConceptScore W2152555903C121332964 @default.
• W2152555903 hasConceptScore W2152555903C187212893 @default.
• W2152555903 hasConceptScore W2152555903C2778866548 @default.
• W2152555903 hasConceptScore W2152555903C2781253189 @default.
• W2152555903 hasConceptScore W2152555903C2908647359 @default.
• W2152555903 hasConceptScore W2152555903C501593827 @default.
• W2152555903 hasConceptScore W2152555903C61511704 @default.
• W2152555903 hasConceptScore W2152555903C71924100 @default.
• W2152555903 hasConceptScore W2152555903C86803240 @default.
• W2152555903 hasConceptScore W2152555903C89423630 @default.

• next